Mills Mike 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Feb 11, 2010
Insider Transaction Report
Form 4
Mills Mike
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2010-02-10$4.34/sh+4,000$17,360→ 4,000 total - Exercise/Conversion
Common Stock
2010-02-10$3.26/sh+1,146$3,736→ 5,146 total - Sale
Common Stock
2010-02-10$7.05/sh−5,146$36,279→ 0 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2010-02-10−4,000→ 0 totalExercise: $4.34From: 2006-06-15Exp: 2015-06-15→ Common Stock (4,000 underlying) - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2010-02-10−1,146→ 3,129 totalExercise: $3.26From: 2009-03-14Exp: 2018-03-14→ Common Stock (1,146 underlying)
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. The prices actually ranged from $7.04 to $7.07. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.